Related Experiment Video
Updated: Aug 13, 2026

06:49
Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
Treatment failure in filariasis mass treatment programmes
Bulletin of the World Health Organization
|January 1, 1971
Summary
Diethylcarbamazine treatment failures in filariasis control were analyzed. New infections were significantly higher in individuals previously infected, indicating a high-risk subgroup needing targeted interventions.
Area of Science:
- Tropical Medicine
- Epidemiology
- Parasitology
Background:
- Filariasis control programs rely on diethylcarbamazine (DEC) treatment.
- Understanding treatment failures is crucial for effective disease management.
- Previous analyses primarily used prevalence, potentially obscuring key epidemiological patterns.
Purpose of the Study:
- To reanalyze data from the Samoan filariasis control program using incidence statistics.
- To differentiate between primary treatment failures, secondary treatment failures, and new infections.
- To identify factors contributing to differential susceptibility or exposure in the population.
Main Methods:
- Reanalysis of 3-year pilot program data from Samoa.
- Application of incidence statistics instead of prevalence.
- Statistical exclusion of persistent and recurrent microfilaraemia cases.
Main Results:
- Diethylcarbamazine treatment failures can be categorized into primary, secondary, and new infections.
- The incidence of new filariasis infections is substantially higher in individuals with a history of microfilaraemia.
- This highlights non-homogeneous distribution of susceptibility or exposure within the population.
Conclusions:
- Current mathematical models of filarial epidemiology require refinement.
- Filariasis control strategies should focus on identifying and targeting high-risk subgroups.
- Further research into susceptibility and exposure factors is warranted for improved public health interventions.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

